Effects of Roflumilast in Hospitalized COPD on Mortality and Re-hospitalization

Trial Profile

Effects of Roflumilast in Hospitalized COPD on Mortality and Re-hospitalization

Recruiting
Phase of Trial: Phase III

Latest Information Update: 26 Oct 2016

At a glance

  • Drugs Roflumilast (Primary)
  • Indications Chronic obstructive pulmonary disease
  • Focus Registrational; Therapeutic Use
  • Most Recent Events

    • 17 Oct 2016 Planned End Date changed from 1 Apr 2017 to 1 Aug 2017.
    • 17 Oct 2016 Planned primary completion date changed from 1 Nov 2016 to 1 Jul 2017.
    • 04 Nov 2015 Planned End Date changed from 1 Apr 2016 to 1 Apr 2017 as reported by ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top